The Asia Pacific Nasal Splints Market would witness market growth of 5.6% CAGR during the forecast period (2024-2031). In the year 2022, the Asia Pacific market's volume surged to 17,211.6 thousand units, showcasing a growth of 16.1% (2020-2023).
Intranasal splints, integral to the Market, serve diverse functions in the realm of nasal care and surgery. These splints are designed to be inserted into the nasal passages. One primary use of intranasal is in septoplasty, where they assist in maintaining the straightened position of the septum post-surgery. Therefore, the China market consumed 3,185.77 thousand units of Intranasal splints in 2023.
The China market dominated the Asia Pacific Nasal Splints Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $163 million by 2031. The Japan market is registering a CAGR of 5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.3% during (2024 - 2031).
An emerging pattern is the growing focus on patient-centered design and customization during the development of nose splints. Customized nose splints, fabricated using advanced imaging techniques such as computed tomography (CT) or three-dimensional (3D) scanning, offer a personalized approach to nasal splint therapy, ensuring optimal fit, comfort, and efficacy while minimizing the risk of complications.
Another trend is the growing adoption of biodegradable and bioresorbable materials in nasal splint manufacturing, driven by the desire to reduce the need for splint removal procedures and minimize patient discomfort associated with prolonged splint wear. Biodegradable nose splints gradually degrade and are absorbed by the body over time, reducing the risk of complications such as granulation tissue formation or mucosal damage.
With increasing awareness campaigns, health education initiatives, and access to information through digital platforms, more people in India are becoming aware of nasal conditions and seeking medical attention for their nasal health concerns. As a result, there is a growing demand for diagnostic evaluations, consultations with otolaryngologists, and surgical interventions, including nasal splint therapy, to address nasal conditions effectively. As per the data published by the National Investment Promotion and Facilitation Agency of India, the hospital industry in India, which accounts for 80% of the entire healthcare industry, is experiencing high investment demand from international and domestic investors. The healthcare industry was expected to rise to $132 billion by 2023. Hence, the expansion of healthcare services in the Asia Pacific region will boost the expansion of the regional market.
Based on Mechanism, the market is segmented into Intranasal, and External. Based on Application, the market is segmented into Septoplasty, and Rhinoplasty. Based on Type, the market is segmented into Malleable, Airway, and Bivalve. Based on End-user, the market is segmented into Outpatients, and Hospitals. Based on Material Type, the market is segmented into Silicon Splints, Plastic Splints, Metal Splints, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Intranasal splints, integral to the Market, serve diverse functions in the realm of nasal care and surgery. These splints are designed to be inserted into the nasal passages. One primary use of intranasal is in septoplasty, where they assist in maintaining the straightened position of the septum post-surgery. Therefore, the China market consumed 3,185.77 thousand units of Intranasal splints in 2023.
The China market dominated the Asia Pacific Nasal Splints Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $163 million by 2031. The Japan market is registering a CAGR of 5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.3% during (2024 - 2031).
An emerging pattern is the growing focus on patient-centered design and customization during the development of nose splints. Customized nose splints, fabricated using advanced imaging techniques such as computed tomography (CT) or three-dimensional (3D) scanning, offer a personalized approach to nasal splint therapy, ensuring optimal fit, comfort, and efficacy while minimizing the risk of complications.
Another trend is the growing adoption of biodegradable and bioresorbable materials in nasal splint manufacturing, driven by the desire to reduce the need for splint removal procedures and minimize patient discomfort associated with prolonged splint wear. Biodegradable nose splints gradually degrade and are absorbed by the body over time, reducing the risk of complications such as granulation tissue formation or mucosal damage.
With increasing awareness campaigns, health education initiatives, and access to information through digital platforms, more people in India are becoming aware of nasal conditions and seeking medical attention for their nasal health concerns. As a result, there is a growing demand for diagnostic evaluations, consultations with otolaryngologists, and surgical interventions, including nasal splint therapy, to address nasal conditions effectively. As per the data published by the National Investment Promotion and Facilitation Agency of India, the hospital industry in India, which accounts for 80% of the entire healthcare industry, is experiencing high investment demand from international and domestic investors. The healthcare industry was expected to rise to $132 billion by 2023. Hence, the expansion of healthcare services in the Asia Pacific region will boost the expansion of the regional market.
Based on Mechanism, the market is segmented into Intranasal, and External. Based on Application, the market is segmented into Septoplasty, and Rhinoplasty. Based on Type, the market is segmented into Malleable, Airway, and Bivalve. Based on End-user, the market is segmented into Outpatients, and Hospitals. Based on Material Type, the market is segmented into Silicon Splints, Plastic Splints, Metal Splints, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Olympus Corporation
- Medtronic PLC
- Smith & Nephew PLC
- Surgiform Technology Ltd. (STL Group, Inc.)
- Teleflex Incorporated
- ENTPROMED Healthcare Products Inc.
- E.Benson Hood Laboratories, Inc.
- Audio Technologies SRL (Innovative-RFK Spa)
- Anthony Products Inc.
- Boston Medical Products, Inc. (Bess AG)
Market Report Segmentation
By Mechanism (Volume, Thousand Units, USD Billion, 2020-31)- Intranasal
- External
- Septoplasty
- Rhinoplasty
- Malleable
- Airway
- Bivalve
- Outpatients
- Hospitals
- Silicon Splints
- Plastic Splints
- Metal Splints
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Nasal Splints Market by Mechanism
Chapter 5. Asia Pacific Nasal Splints Market by Application
Chapter 6. Asia Pacific Nasal Splints Market by Type
Chapter 7. Asia Pacific Nasal Splints Market by End-user
Chapter 8. Asia Pacific Nasal Splints Market by Material Type
Chapter 9. Asia Pacific Nasal Splints Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Olympus Corporation
- Medtronic PLC
- Smith & Nephew PLC
- Surgiform Technology Ltd. (STL Group, Inc.)
- Teleflex Incorporated
- ENTPROMED Healthcare Products Inc.
- E. Benson Hood Laboratories, Inc.
- Audio Technologies SRL (Innovative-RFK Spa)
- Anthony Products Inc.
- Boston Medical Products, Inc. (Bess AG)
Methodology
LOADING...
